Overexpression or hyperactivation of SIRT1 is closely associated with poor prognosis, metastasis, chemoresistance, and oxidative stress resistance in multiple cancer types, including ovarian, liver, breast, and lung cancers. The gene discussed is SIRT1; the disease is lung carcinoma.